Cargando…

Does Statin Therapy Reduce the Risks of Mortality and Major Adverse Cardiac and Cerebrovascular Events in Young Adults with End-Stage Renal Disease? Population-Based Cohort Study

Among hemodialysis patients aged more than 40 years old, previous large-scale studies showed statin treatment had no effect on reducing cardiovascular adverse events. However, young-adult-onset end-stage renal disease (ESRD) patients have different physicosocial factors compared to older ESRD patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Ya-Lien, Yang, Huang-Yu, Wu, Chao-Yi, Tsai, Chung-Ying, Chen, Chao-Yu, Hsiao, Ching-Chung, Hsu, Hsiang-Hao, Tian, Ya-Chung, Yen, Chieh-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152985/ https://www.ncbi.nlm.nih.gov/pubmed/34068144 http://dx.doi.org/10.3390/jcm10102097

Ejemplares similares

Does a Supplemental Low-Protein Diet Decrease Mortality and Adverse Events After Commencing Dialysis? A Nationwide Cohort Study
por: Yen, Chieh-Li, et al.
Publicado: (2018)

Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006–2016
por: Lin, Min-Hao, et al.
Publicado: (2020)

The burden of major adverse cardiac events in patients with coronary artery disease
por: Tsai, I-Ting, et al.
Publicado: (2017)

Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study
por: Ho, Wen-Yu, et al.
Publicado: (2022)

Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke
por: Tu, Wen-Jun, et al.
Publicado: (2020)

Cerebrovascular Disease and Statins
por: Beltrán Romero, Luis M., et al.
Publicado: (2021)

In-Hospital Outcomes and Recurrence of Infectious Spondylitis in Patients with and without Chronic Hemodialysis: A Nationwide Cohort Study
por: Lu, Yueh-An, et al.
Publicado: (2022)

Impact of statin intensity on adverse cardiac and cerebrovascular events in older adult patients with myocardial infarction
por: Moon, In Tae, et al.
Publicado: (2021)

Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: A retrospective cohort study
por: Steenhuis, Dennis, et al.
Publicado: (2023)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Kao, Yu-Cheng, et al.
Publicado: (2021)

Infarction Patterns and Recurrent Adverse Cerebrovascular Events in Moyamoya Disease
por: Yu, Shao-Chen, et al.
Publicado: (2022)

Real-time AI prediction for major adverse cardiac events in emergency department patients with chest pain
por: Zhang, Pei-I, et al.
Publicado: (2020)

Renal Function-Dependent Associations of Statins with Outcomes of Ischemic Stroke
por: Yeh, Shin-Joe, et al.
Publicado: (2021)

Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis
por: Zhong, Ping, et al.
Publicado: (2017)

Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease
por: Yen, Chieh‐Li, et al.
Publicado: (2022)

Comparison of the Effects of High-intensity Statin Therapy with Moderate-Intensity Statin and Ezetimibe Combination Therapy on Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction: a Nationwide Cohort Study
por: Kim, Kihyun, et al.
Publicado: (2021)

Prevalence and trends of perioperative major adverse cardiovascular and cerebrovascular events during cancer surgeries
por: Ramamoorthy, Venkataraghavan, et al.
Publicado: (2023)

The Effect of Statin on Anemia in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis
por: Tsai, Meng-Hsu, et al.
Publicado: (2022)

Sex Differences in the Development of Malignancies among End-Stage Renal Disease Patients: A Nationwide Population-Based Follow-Up Study in Taiwan
por: Chung, Chi-Jung, et al.
Publicado: (2012)

Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study
por: Chen, Yen-Fu, et al.
Publicado: (2019)

Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome
por: Baluja, Aurora, et al.
Publicado: (2019)

Major Adverse Cardiac and Cerebrovascular Events in Patients Undergoing Simultaneous Heart Surgery and Carotid Endarterectomy
por: Gerfer, Stephen, et al.
Publicado: (2023)

Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans
por: Sun, Ji, et al.
Publicado: (2022)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

Herpes Zoster Is Associated with Prior Statin Use: A Population-Based Case-Control Study
por: Chung, Shiu-Dong, et al.
Publicado: (2014)

Ketoanalogues Supplemental Low Protein Diet Safely Decreases Short-Term Risk of Dialysis among CKD Stage 4 Patients
por: Yen, Chieh-Li, et al.
Publicado: (2022)

Comparison of the clinical features and outcomes of infective endocarditis between hemodialysis and non-hemodialysis patients
por: Hsiao, Ching-Chung, et al.
Publicado: (2017)

Low TLR7 gene expression in atherosclerotic plaques is associated with major adverse cardio- and cerebrovascular events
por: Karadimou, Glykeria, et al.
Publicado: (2017)

Identification of potentially inappropriate medications with risk of major adverse cardio- and cerebrovascular events among elderly patients
por: Lima, Joana C. F., et al.
Publicado: (2021)

Long‐Term Blood Pressure Variability and Major Adverse Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage
por: Castello, Juan Pablo, et al.
Publicado: (2022)

Major Adverse Cardiac and Cerebrovascular Events in Geriatric Patients with Obstructive Sleep Apnea: An Inpatient Sample Analysis
por: Desai, Rupak, et al.
Publicado: (2023)

Supplemented Low-Protein Diet May Delay the Need for Preemptive Kidney Transplantation: A Nationwide Population-Based Cohort Study
por: Yen, Chieh-Li, et al.
Publicado: (2021)

Antioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease
por: Moon, Gyeong Joon, et al.
Publicado: (2014)

Creation and Validation of an EMR-based Algorithm for Identifying Major Adverse Cardiac Events while on Statins
por: Wei, Wei-Qi, et al.
Publicado: (2014)

Angiotensin Receptor Blockers Decrease the Risk of Major Adverse Cardiovascular Events in Patients with End-Stage Renal Disease on Maintenance Dialysis: A Nationwide Matched-Cohort Study
por: Yang, Chung-Wei, et al.
Publicado: (2015)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

Association of Statin Therapy With Major Adverse Cardiovascular and Limb Outcomes in Patients With End-stage Kidney Disease and Peripheral Artery Disease Receiving Maintenance Dialysis
por: Lo, Hao-Yun, et al.
Publicado: (2022)

Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
por: Jiao, Xue-feng, et al.
Publicado: (2020)

Increased Risk of End-Stage Renal Disease in Patients with Renal Cell Carcinoma: A 12-Year Nationwide Follow-Up Study
por: Hung, Peir-Haur, et al.
Publicado: (2014)

Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study
por: Yen, Chieh-Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fkkbr5lf25lijtc7j50kae1k05